減少したTBX5依存遺伝子調節ネットワークは,心房細動と心不全を結びつける
Sonja Lazarevic1, Carlos Perez-Cervantes1, Zhezhen Wang1
1Department of Pediatrics, Pathology, and Human Genetics, University of Chicago, Chicago, IL, USA.
Nature cardiovascular research
|February 23, 2026
まとめ
心房細動 (AF) と心不全 (HF) は,遺伝子調節の障害を含む分子メカニズムを共有しています. TBX5のような重要な転写因子はダウンレギュレーションされ,共通のゲノム損傷反応がそれらの接続の基礎であることを示唆しています.
科学分野:
- 心血管生物学 心血管生物学
- 分子遺伝学 分子遺伝学
- システム生物学 システム生物学
背景:
- 心房細動 (AF) と心不全 (HF) はしばしば共存し,患者のアウトカムを悪化させます.
- 共有された分子経路が,AFとHFの双方向的な関係に根底にあるかもしれない.
研究 の 目的:
- AFとHFのマウスモデルにおける心房遺伝子調節ネットワーク (GRNs) を比較することによって共有された分子メカニズムを調査する.
- 心房組織における一般的な転写およびゲノム変異を特定する.
主な方法:
- Tbx5条件ノックアウト (Tbx5 cKO) マウス (AFモデル) と横動脈狭窄 (TAC) マウス (HFモデル) の心房遺伝子調節ネットワーク (GRNs) の比較.
- トランスクリプション因子遺伝子不調を中心に,心房トランスクリプションとゲノムプロファイルの分析.
主要な成果:
- AFとHFの両方のモデルで,心房の転写およびゲノムプロファイルに高度に相関する変化が観察されました.
- 下調された心房Tbx5発現は,マウスとヒトの両方のHFで発見されました.
- 100以上の転写因子遺伝子が協調的に失調し,TBX5駆動のGRNが破壊され,Sox9-関連ネットワークが生まれました.
結論:
- TBX5依存性心房遺伝子調節の協調的な障害は,AFとHFの両方で発生します.
- 共有されたゲノム損傷反応は,AFとHFの相互リスクに寄与する可能性があります.
- これらの共通のメカニズムを特定すると,新たな治療戦略が生まれます.
関連する概念動画
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Mechanism of Cardiac Arrhythmias
2.4K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Regulation of Heart Rates
4.3K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
4.3K


